Nivalis Therapeutics' Unattributed VC Round

Nivalis Therapeutics raised a round of funding on May 21, 2010.

Nivalis Therapeutics, formerly N30Pharma, is developing a novel class of disease modifying therapies that are designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule wit…

Articles about Nivalis Therapeutics' Unattributed VC Round: